Warren Eric (CIK 1916048) reported 7 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-23). Recent activity: Buy MLYS (7,438 shares), Sell MLYS (7,438 shares), Buy MLYS (104,124 shares), Sell MLYS (104,124 shares), Sell ESPR (108 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-23 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Buy | 7,438 | $98,479 |
| 2026-07-23 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Sell | 7,438 | $199,885 |
| 2026-06-30 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Buy | 104,124 | $1.4M |
| 2026-06-30 | Mineralys Therapeutics, Inc. (MLYS) | Chief Commercial Officer | Sell | 104,124 | $2.7M |
| 2025-04-21 | Esperion Therapeutics, Inc. (ESPR) | Chief Commercial Officer | Sell | 108 | $106 |
| 2025-03-19 | Esperion Therapeutics, Inc. (ESPR) | Chief Commercial Officer | Sell | 2,433 | $3,625 |
| 2025-03-17 | Esperion Therapeutics, Inc. (ESPR) | Chief Commercial Officer | Buy | 213,000 | $0 |
Source: SEC Form 4 filings · as of 2026-07-23